Fulvestrant
Not Tagged
['bcsm']
results of the sonia academic phase 3 study testing 1st vs 2nd line cdk4/6i + et have just been presented at #asco23 . how convinced are you? would you delay cdk4/6i to 2nd line given these results? do you expect changes in guidelines? any practice change in ?
#bcsm 
Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Views are mine https://t.co/F0nn6X9z9N…